
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
47%
Total
Publications
2.3K
Total Open
Publications
1.1K
Total
Citations
49K
Open Access
Percentage
47%
Total
Publications
2.3K
Total Open
Publications
1.1K
Total
Citations
49K
Breakdown
Publisher Open
17%
Both
25%
Other Platform Open
5%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
337
Hybrid 35%
328
No Guarantees 30%
288
Other Platform Open
Domain 66%
449
Institution 61%
412
Other Internet 19%
129
Preprint 4%
28
Public 4%
26
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 462 |
doaj.org OAI-PMH Repository | Institution | 193 |
DOI | Other Internet | 74 |
Unknown Repository | Other Internet | 63 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 44 |
Europe PMC | Domain | 30 |
Figshare | Public | 23 |
King's College London | Institution | 12 |
University of Groningen | Institution | 11 |
University of Copenhagen | Institution | 11 |